Fresenius SE & Co KGaA (FRA:FRE) Given a €54.00 Price Target at Independent Research

Independent Research set a €54.00 ($62.79) target price on Fresenius SE & Co KGaA (FRA:FRE) in a research note issued to investors on Monday, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.

Several other research analysts also recently weighed in on the company. Deutsche Bank set a €65.00 ($75.58) price target on Fresenius SE & Co KGaA and gave the stock a buy rating in a research note on Friday, February 21st. Nord/LB set a €58.00 ($67.44) price objective on shares of Fresenius SE & Co KGaA and gave the company a buy rating in a research report on Tuesday, October 29th. Berenberg Bank set a €72.10 ($83.84) price objective on shares of Fresenius SE & Co KGaA and gave the company a buy rating in a research report on Monday. Goldman Sachs Group set a €53.00 ($61.63) target price on shares of Fresenius SE & Co KGaA and gave the stock a buy rating in a report on Thursday, February 20th. Finally, JPMorgan Chase & Co. set a €59.40 ($69.07) target price on shares of Fresenius SE & Co KGaA and gave the stock a buy rating in a research report on Thursday, February 20th. Eight research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. The company currently has a consensus rating of Buy and a consensus price target of €56.57 ($65.78).

Shares of FRE opened at €45.83 ($53.29) on Monday. The business’s 50 day moving average is €48.39 and its 200 day moving average is €46.70. Fresenius SE & Co KGaA has a 12-month low of €60.16 ($69.95) and a 12-month high of €80.00 ($93.02).

About Fresenius SE & Co KGaA

Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure.

Featured Story: Profit Margin

Analyst Recommendations for Fresenius SE & Co KGaA (FRA:FRE)

Receive News & Ratings for Fresenius SE & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.